HLB Therapeutics Co.,Ltd. HLB Therapeutics Co.,Ltd.

HLB Therapeutics Co.,Ltd.

115450

Classifica tra le azioni #18747
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Prezzo delle azioni
$1.86
Capitalizzazione di mercato
$175.63M
Variazione (1 giorno)
-0.92%
Variazione (1 anno)
-11.13%
Paese
KR
Scambia HLB Therapeutics Co.,Ltd. (115450)

Categoria

Healthcare
Storico dividendi per HLB Therapeutics Co.,Ltd. (115450)
HLB Therapeutics Co.,Ltd. (simbolo azionario: 115450) ha effettuato un totale di 0 pagamenti di dividendi.
La somma totale dei dividendi (rettificata per split azionari) è: 0.00
Rendimento da dividendo (TTM): 0
Pagamenti dei dividendi per HLB Therapeutics Co.,Ltd. (115450) dal 2026 al 2026
Pagamenti annuali dei dividendi
Anno Dividendo (rettificato per split azionari) Cambia
Non abbastanza dati per le date fornite.
Elenco di tutti i pagamenti di dividendi
Anno Dividendo Cambia
Non abbastanza dati per le date fornite.
Dividendi di aziende simili o concorrenti
Azienda Numero di pagamenti di dividendi Il paese
0.00%
US
0.00%
US
64.00%
AU
0.00%
CH
0.00%
NL